Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gregor James Macdonald

Gregor James Macdonald, Harlow GB

Patent application numberDescriptionPublished
20080214571NOVEL COMPOUNDS - Disclosed is a method for use of phenyl sulfone compounds of formula (I) in the treatment of anxiety.09-04-2008
20090012099Novel Compounds - Disclosed is a method for use of phenyl sulfone compounds of formula (I) in the treatment of Alzheimer's disease and age related cognitive decline.01-08-2009
20090036682Quinoline Derivatives and Their Use as 5-HT6 Ligands - The present invention relates to novel quinoline compounds having pharmacological activity, to processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders.02-05-2009
20100305107QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS - Disclosed are quinoline compounds having affinity for the 5-HT12-02-2010
20110237792QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS - Disclosed are quinoline compounds having affinity for the 5-HT09-29-2011

Patent applications by Gregor James Macdonald, Harlow GB

Gregor James Macdonald, Beerse BE

Patent application numberDescriptionPublished
201001666551, 4-DISUBSTITUTED 3-CYANO-PYRIDONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS - The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I)07-01-2010
201002406881,3-DISUBSTITUTED-4-PHENYL-3,4,5,6-TETRAHYDRO-2H,1 H-1,4 BIPYRIDINYL-2-ONES - The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I)09-23-2010
201002407061,3-DISUBSTITUTED-4-PHENYL-1H-PYRIDIN-2-ONES - The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I)09-23-2010
201002862061,3-DISUBSTITUTED 4-(ARYL-X-PHENYL)-1H-PYRIDIN-2-ONES - The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I)11-11-2010

Gregor James Macdonald, Zoersel GB

Patent application numberDescriptionPublished
201000630923-CYANO-4-(4-PHENYL-PIPERIDIN-1-YL)-PYRIDIN-2-ONE DERIVATIVES - The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I) including any stereochemically isomeric form thereof, or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein all radicals are defined in the application and claims. The compounds according to the invention are positive allosteric modulators of metabotropic glutamate receptors subtype 2 (“mGluR2”) which are useful for the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 subtype of metabotropic receptors is involved. In particular, such diseases are central nervous system disorders selected from the group of anxiety, schizophrenia, migraine, depression, and epilepsy. The invention is also directed to pharmaceutical compositions and processes to prepare such compounds and such compositions, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR2 is involved.03-11-2010

Gregor James Macdonald, Essex GB

Patent application numberDescriptionPublished
20080306083Biaryl Compounds Useful as Agonists of the Gpr38 Receptor - The present invention relates to novel biaryl derivatives such as compounds of formula (I), which have activity as agonists of the GPR38 receptor and the use of such compounds or pharmaceutical compositions thereof in the treatment of gastrointestinal disorders.12-11-2008
20080312209Piperazine Heteroaryl Derivatives as Gpr38 Agonists - The invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof,12-18-2008
20090298841QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS - The present invention relates to novel quinoline compounds having pharmacological activity, to processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders.12-03-2009

Gregor James Macdonald, Emblem BE

Patent application numberDescriptionPublished
20080227791Piperidin-4-Yl-Pyridazin-3-Ylamine Derivatives as Fast Dissociating Dopamine 2 Receptor Antagonists - The present invention relates to compounds that are fast dissociating dopamine 2 receptor antagonists, processes for preparing these compounds, pharmaceutical compositions comprising these compounds as an active ingredient. The compounds find utility as medicines for treating or preventing central nervous system disorders, for example schizophrenia, by exerting an antipsychotic effect without motor side effects.09-18-2008

Gregor James Macdonald, Ranst BE

Patent application numberDescriptionPublished
201102697482-ANILINE-4-ARYL SUBSTITUTED THIAZOLE DERIVATIVES - This invention concerns the use of a compound of formula (I)11-03-2011